Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease

Gastroenterologia y Hepatologia

Volumn 34, Issue 6, 2011, Pages 385-392

  López Martín, Cristina ^a   Chaparro, María ^a   Espinosa, Laura ^a   Bejerano, Alicia ^a   Maté, José ^a   Gisbert, Javier P ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Adverse events; Azathioprine; Hepatotoxicity; Inflammatory bowel disease; Mercaptopurine; Myelotoxicity; Pancreatitis; Thiopurine

Indexed keywords

AZATHIOPRINE; CIPROFLOXACIN; CORTICOSTEROID; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; IMIPENEM; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; SALAZOSULFAPYRIDINE; THIOPURINE METHYLTRANSFERASE; VANCOMYCIN;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; BONE MARROW TOXICITY; CHOLURIA; CROHN DISEASE; DISEASE CLASSIFICATION; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; ESOPHAGOGASTRODUODENOSCOPY; FATIGUE; FEMALE; FEVER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; GROUPS BY AGE; HEARING IMPAIRMENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; JAUNDICE; LEUKOPENIA; LIVER BIOPSY; LIVER HYPERPLASIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEOPLASM; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL HYPERTENSION; RASH; RECOMMENDED DRUG DOSE; RETROSPECTIVE STUDY; RISK FACTOR; SIDE EFFECT; SMOKING; THROMBOCYTOPENIA; ULCERATIVE COLITIS; VIRUS PNEUMONIA; VOMITING;

6-MERCAPTOPURINE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AZATHIOPRINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79959243085     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2011.03.023     Document Type: Article

References (30)

1. Lichtenstein G.R., Abreu M.T., Cohen R., Tremaine W. American Gastroenterological Association Institute technical review on corticosteroids, inmunomodulators, and infliximab in inflamatory bowel disease. Gastroenterology 2006, 130:940-987.
2. Gisbert J.P., Gomollón F., Maté J., Pajares J.M. Individualized therapy with azathioprine or 6-mercaptopurine by monitoring thiopurine methyl-transferase (TPMT) activity. Rev Clin Esp 2002, 202:555-562.
3. Gisbert J.P., Gomollón F., Cara C., Luna M., González-Lama Y., Pajares J.M., et al. Thiopurine methyl-transferase (TPMT) activity in Spain: a study of 14,545 patients. Dig Dis Sci 2007, 52:1262-1269.
4. Saibeni S., Virgilio T., D'Inca R., Spina L., Bortoli A., Paccagnella M., et al. The use of thiopurines for the treatment of inflammatory bowel diseases in clinical practice. Dig Liver Dis 2008, 40:814-820.
5. Su C.G., Stein R.B., Lewis J.D., Lichtenstein G.R. Azathioprine or 6-mercaptopurine for inflammatory bowel disease: do risk outweigh benefits?. Dig Liver Dis 2000, 32:518-531.
6. Present D.H., Meltzer S.J., Krumholz M.P., Wolke A., Korelitz B.I. 6-Mercaptopurine in the management of inflammatory bowel disease: short and long-term toxicity. Ann Intern Med 1989, 111:641-649.
7. Martínez F., Nos P., Pastor M., Garrigues V., Ponce J. Adverse effects of azathioprine in the treatment of inflammatory bowel disease. Rev Esp Enferm Dig 2001, 93:774-778.
8. Warman J.I., Korelitz B.I., Fleisher M.R., Janardhanam R. Cumulative experience with short and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis. J Clin Gastroenterol 2003, 7:220-225.
9. Silverberg M., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., et al. Toward and integrated clinical, molecular, and serological classification of inflammatory bowel disease: report or a working party of the Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19:5A-36A.
10. Connell W.R., Kamm M.A., Ritchie J.K., Lennard-Jones J.E. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut 1993, 34:1081-1085.
11. Gisbert J.P., Gomollón F. Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review. Am J Gastroenterol 2008, 103:1783-1800.
12. Gisbert J.P., Luna M., González-Lama Y., Pousa I.D., Velasco M., Moreno-Otero R., et al. Liver injury in inflamatory bowel disease: long- term follow-up study of 786 patients. Inflamm Bowel Dis 2007, 13:1106-1114.
13. Gisbert J.P., González-Lama Y., Maté J. Thiopurine-induced liver injury in patients with inflamatory bowel disease: a sistematyc review. Am J Gastroenterol 2007, 102:1518-1527.
14. Kirschner B.S. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease. Gastroenterology 1998, 115:813-821.
15. Seksik P., Cosnes J., Sokol H., Nion-Larmurier I., Gendre J.P., Bleaugerie L. Incidence of benign upper respiratory tract infections, HSV an HPV cutaneous infections in inflammatory bowel disease patients with azathioprine. Aliment Pharmacol Ther 2009, 29:1106-1113.
16. Castiglione F., Del Vecchio Blanco G., Rispo A., Cozzolino A., Di Girolamo E., Cappuccio D., et al. Hepatitis related to cytomegalovirus infection in two patients with Crohn's disease treated with azathioprine. Dig Liver Dis 2000, 32:626-629.
17. Pearson D.C., May G.R., Fick G.H., Sutherland L.R. Azathioprine and 6-mercaptopurine in Crohn disease. Ann Intern Med 1995, 123:132-142.
18. Bastida G., Nos P., Aguas M., Beltrán B., Rubín A., Dasí F., et al. Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2005, 22:775-782.
19. Dubinsky M.C., Vasiliauskas E.A., Singh H., Abreu M.T., Papadakis K.A., Tran T., et al. 6-Thioguanine can cause serious liver injury in inflammatory bowel disease patients. Gastroenterology 2003, 125:298-303.
20. Mion F., Napoleon B., Berger F., Chevallier M., Bonvoisin S., Descos L. Azathioprine induced liver disease: nodular regenerative hyperplasia of the liver and perivenous fibrosis in a patient treated for multiple sclerosis. Gut 1991, 32:715-717.
21. Arnott I.D., Ghosh S. Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury. Eur J Gastroenterol Hepatol 2000, 12:569-573.
22. Russmann S., Zimmermann A., Krähenbühl S., Kern B., Reichen J. Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis. Eur J Gastroenterol Hepatol 2001, 13:287-290.
23. Seiderer J., Zech C.J., Diebold J., Schoenberg S.O., Brand S., Tillack C., et al. Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy. Eur J Gastroenterol Hepatol 2006, 18:553-555.
24. Vernier-Massouille G., Cosnes J., Lemann M., Marteau P., Reinisch W., Laharie D., et al. Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine. Gut 2007, 56:1404-1409.
25. Seiderer J., Zech C.J., Walter R., Lukas M., Diebold J., Wrba F., et al. A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine. J Hepatol 2005, 43:303-309.
26. Bermejo F., López-San Roman A., Taxonera C., Gisbert J.P., Pérez-Calle J.L., Vera I., et al. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis. Aliment Pharmacol Ther 2008, 28:623-628.
27. Weersma R.K., Peters F.T., Oostenbrug L.E., Van den Berg A.P., Van Haastert M., Ploeg R.J., et al. Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases. Aliment Pharmacol Ther 2004, 20:843-850.
28. Korelitz B.I., Zlatanic J., Goel F., Fuller S. Allergic reactions to 6-mercaptopurine during treatment of inflammatory bowel disease. J Clin Gastroenterol 1999, 28:341-344.
29. Bowen D.G., Selby W.S. Use of 6-mercaptopurine in patients with inflammatory bowel disease previosly intolerant of azathioprine. Dig Dis Sci 2000, 45:1810-1813.
30. Doménech E., Nos P., Papo M., López-San Román A., García-Planella E., Gassull M.A. 6-mercaptopurine in patients with inflammatory bowel disease and previous digestive intolerance of azathioprine. Scand J Gastroenterol 2005, 40:52-55.